Cell Machines
Jump to navigation
Jump to search
We have developed a scalable, multipurpose system for production of human therapeutic proteins that provides us with a tremendous cost advantage. Our first product is factor IX for the treatment of hemophilia B. This is currently an underserved $1.4 billion market. ...
| Cell Machines | |
|---|---|
| Startup Information | |
| Website | cellmachines.net |
| Industry | Therapeutics |
| Accelerator | |
| Accelerator (Other) | |
| Founder | |
| Founding Date | |
| Street Address | |
| City | |
| Zip Code | |
| Copyright © 2016 McNair Center. All Rights Reserved. | |
